These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Induction of subcapsular cataracts in aniridic vervet monkeys by echothiophate. Kaufman PL; Axelsson U Invest Ophthalmol; 1975 Nov; 14(11):863-6. PubMed ID: 810455 [TBL] [Abstract][Full Text] [Related]
45. Lenticular opacities in glaucoma patients receiving echothiophate iodide therapy. Preliminary report. De Roetth A JAMA; 1966 Feb; 195(8):664-6. PubMed ID: 5951770 [No Abstract] [Full Text] [Related]
46. Early effects of single and repeated doses of L-epinephrine in man. Kronfeld PC Am J Ophthalmol; 1971 Dec; 72(6):1058-72. PubMed ID: 5128111 [No Abstract] [Full Text] [Related]
47. How safe are ocular drugs in pediatrics? Palmer EA Ophthalmology; 1986 Aug; 93(8):1038-40. PubMed ID: 3763151 [TBL] [Abstract][Full Text] [Related]
48. Allergic contact dermatitis to echothiophate iodide and phenylephrine. Mathias CG; Mailbach HI; Irvine A; Adler W Arch Ophthalmol; 1979 Feb; 97(2):286-7. PubMed ID: 550798 [No Abstract] [Full Text] [Related]
49. Echothiophate iodide for glaucoma or flat anterior chamber following cataract extraction. Gorin G Am J Ophthalmol; 1969 Mar; 67(3):392-5. PubMed ID: 5774254 [No Abstract] [Full Text] [Related]
50. General anesthesia for cataract surgery: a comparative review of 2217 consecutive cases. Lynch S; Wolf GL; Berlin I Anesth Analg; 1974; 53(6):909-13. PubMed ID: 4473935 [No Abstract] [Full Text] [Related]
52. Miosis from echothiophate in patients with total oculomotor nerve paralysis from intracranial abnormalities. Mindel JS Am J Ophthalmol; 1981 Mar; 91(3):373-80. PubMed ID: 7211995 [TBL] [Abstract][Full Text] [Related]
53. Echothiophate iodide therapy in children. Effect upon blood cholinesterase levels. Ellis PP; Esterdahl M Arch Ophthalmol; 1967 May; 77(5):598-601. PubMed ID: 6022729 [No Abstract] [Full Text] [Related]
54. Autonomic drugs in ophthalmology: some problems and promises. I. Directly and indirectly acting parasympathomimetic drugs. Holland MG Ann Ophthalmol; 1974 May; 6(5):447-50 passim. PubMed ID: 4208894 [No Abstract] [Full Text] [Related]
55. Anticholinesterase drugs and cataracts. Shaffer RN; Hetherington J Trans Am Ophthalmol Soc; 1966; 64():204-16. PubMed ID: 6007355 [No Abstract] [Full Text] [Related]
56. Glaucoma, miotic therapy and cataract. V. Studies on the lens in glaucoma eyes after discontinuance of echothiophate (phospholine iodide) therapy. Axelsson U Acta Ophthalmol (Copenh); 1969; 47(4):1049-56. PubMed ID: 5394838 [No Abstract] [Full Text] [Related]
57. Echothiophate iodide: its use in accommodative esotropia (high Ac/A ratio). Reddy RH Indian J Ophthalmol; 1982 Jul; 30(4):225. PubMed ID: 7166393 [No Abstract] [Full Text] [Related]
58. Subsensitivity to pilocarpine of the aqueous outflow system in monkey eyes after topical anticholinesterase treatment. Kaufman PL; Bárány EH Am J Ophthalmol; 1976 Dec; 82(6):883-91. PubMed ID: 826164 [TBL] [Abstract][Full Text] [Related]
59. [Phospholine iodide and opacity of the lens]. Dake CL; Kerlen CH Ned Tijdschr Geneeskd; 1968 Oct; 112(42):1898-901. PubMed ID: 5686456 [No Abstract] [Full Text] [Related]
60. Adverse effects of topical antiglaucoma drugs. Med Lett Drugs Ther; 1967 Nov; 9(23):92-3. PubMed ID: 6069648 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]